These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25976278)

  • 1. VKORC1 -1639 G>A Polymorphism in Romanian Patients With Deep Vein Thrombosis.
    Vesa ŞC; Trifa AP; Crişan S; Buzoianu AD
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):760-764. PubMed ID: 25976278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two prediction scores for the risk of acute lower extremity deep vein thrombosis.
    Pop TR; Vesa ŞC; Trifa AP; Crişan S; Buzoianu AD
    Rom J Morphol Embryol; 2014; 55(1):153-7. PubMed ID: 24715181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
    Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
    Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
    Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G;
    Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between inherited thrombophilia and impaired right ventricular function in deep vein thrombosis without symptomatic pulmonary embolism.
    Asgun HF; Kirilmaz B; Saygi S; Ozturk O; Silan F; Karatag O; Kosar S; Ozdemir O
    Clin Appl Thromb Hemost; 2014 Apr; 20(3):270-7. PubMed ID: 22992348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.
    Coulam CB; Wallis D; Weinstein J; DasGupta DS; Jeyendran RS
    Am J Reprod Immunol; 2008 Nov; 60(5):426-31. PubMed ID: 18803625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
    Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilia testing in patients with venous thrombosis.
    Caprini JA; Goldshteyn S; Glase CJ; Hathaway K
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):550-5. PubMed ID: 16055356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry.
    Linnemann B; Meister F; Schwonberg J; Schindewolf M; Zgouras D; Lindhoff-Last E;
    Thromb Haemost; 2008 Sep; 100(3):440-6. PubMed ID: 18766260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.
    Azzam H; Elwakeel H; Awad I; El-Farahaty R; El-Gilany AH; El-Sharawy S
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):121-6. PubMed ID: 24978953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.
    Al-Allawi NA; Badi AI; Goran MA; Nerweyi FF; Ballo HM; Al-Mzury NT
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):500-4. PubMed ID: 26196588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of point mutations in the genes, predisposing inherited thrombophilia in the pathogeneses of proximal and distal deep vein thrombosis in Georgian population.
    Pirtskhelani N; Kochiashvili N; Makhaldiani L; Pargalava N; Gaprindashvili E; Kartvelishvili K
    Georgian Med News; 2014 Feb; (227):98-102. PubMed ID: 24632657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep venous thrombosis and thrombophilic mutations in western Iran: association with factor V Leiden.
    Rahimi Z; Mozafari H; Shahriari-Ahmadi A; Alimogaddam K; Ghavamzadeh A; Aznab M; Mansouri K; Rezaei M; Parsian A
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):385-8. PubMed ID: 20479641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia.
    Bedencic M; Bozic M; Peternel P; Stegnar M
    Pathophysiol Haemost Thromb; 2008; 36(2):58-63. PubMed ID: 19127083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study.
    Lacut K; Larramendy-Gozalo C; Le Gal G; Duchemin J; Mercier B; Gourhant L; Mottier D; Becquemont L; Oger E; Verstuyft C
    J Thromb Haemost; 2007 Oct; 5(10):2020-4. PubMed ID: 17883698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.